Therapeutic Penetrating Keratoplasty using Full-Thickness Gamma Irradiated Corneal Tissue 1; Gustavo A. Corrales, M.D. 2; Sina J. Sabet M.D., F.A.C.S 3; Bhaskar Kallakury, M.D. 4; Eileen Rusnock 5; Cameron J. Sabet 6; Esen K. Akpek, M.D. 1 Cornea and External Disease Service, Medstar - Washington Hospital Center, Washington, DC, USA 2 Departments of Ophthalmology and Pathology, Medstar - Georgetown University Medical Center, Washington DC, USA and Neuro-Ophthalmology Section, Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA 3 Department of Pathology, Medstar - Georgetown University Medical Center, Washington DC, USA 4 Department of Pathology, Medstar - Georgetown University Medical Center, Washington DC, USA 5 Dartmouth College, Hanover, New Hampshire, USA 6 Ocular Surface Disease and Dry Eye Clinic, Cornea and External Disease Service, The Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA Running Head: Penetrating Keratoplasty Using VisionGraft® Corresponding Author Gustavo A. Corrales, M.D. Cornea and External Disease Service, Medstar Washington Hospital Center 110 Irving St NW, Washington, DC 20010 Phone: 703-532-0728 Fax: 888-972-9036 Email: gcorrales@novavcs.com Highlights: - VisionGraft® is a commercially available acellular gamma-irradiated sterile cornea.